Tumors exhibiting high staining intensity (3) were classified as potentially over-expressing, with 70 out of 258 (27.1%) and 51 out of 295 (17.3%) of tumor samples over-expressing cortactin and FADD, respectively. The gene discussed is CTTN; the disease is neoplasm.